Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to assess the levels of neuregulin-4 and its receptor ErbB4 in the GCF and saliva in stage III and IV periodontitis patients with and without type 2 diabetes mellitus.
The aim of this study is to measure the levels of Nrg4 and ErbB4 in the GCF and saliva of periodontitis stage III and IV patients with and without type 2 diabetes mellitus and to correlate their levels with the periodontal clinical parameters and the blood glucose levels including the fasting plasma glucose level (FPG) and glycated hemoglobin (HbA1c).
This study will be conducted in the Oral Medicine and Periodontology department, Faculty of Dentistry- Cairo University, Egypt.
Patients will be selected from the outpatient clinic of the department of Oral Medicine and Periodontology, Faculty of Dentistry-Cairo University.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Neuregulin-4 in the GCF | Measured by Enzyme-Linked Immunosorbent Assay in μL | 6 month |
| The receptor ErbB4 in the GCF | Measured by Enzyme-Linked Immunosorbent Assay in μL | 6 month |
| Neuregulin-4 in the saliva | Measured by Enzyme-Linked Immunosorbent Assay in μL | 6 month |
| The receptor ErbB4 in saliva | Measured by Enzyme-Linked Immunosorbent Assay in μL | 6 month |
| Measure | Description | Time Frame |
|---|---|---|
| Pocket depth | Measured by Manual UNC periodontal probe in mm | 6 month |
| Clinical attachment level | Measured by Manual UNC periodontal probe in mm |
Not provided
Inclusion Criteria:
For periodontitis stage III and IV patients according to (Papapanou et al., 2018 and Tonetti et al., 2018)
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Dental patients will be recruited in a consecutive manner from the clinic of the department of Oral Medicine and Periodontology, Faculty of Dentistry -Cairo University.
Medical history and dental history will be taken; thorough oral examination will be done.
The aim of the study will be explained to the patient and the patient's acceptance to participate in the survey will be received.
Non-respondent patients or patients refusing to participate will be reported with the cause of their refusal.
Conventional oral and periodontal examination will be held on a dental unit using the light of the unit, mirror and probe
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Asmaa Samir, Master | Contact | 01000797021 | Asmaaabdelfatah@dentistry.cu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Asmaa samir, master | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo university Faculty of dentistry | Recruiting | Cairo | Egypt |
Not provided
| ID | Term |
|---|---|
| D010518 | Periodontitis |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D044882 | Glucose Metabolism Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 month |
| Bleeding on probing | Measured by Manual UNC periodontal probe by gently probing the orifice of the gingival crevice, the periodontal probe will be inserted 1 to2 mm into the gingival sulcus starting at one interproximal area and moving to the other. If bleeding occurs within 10 seconds a positive finding is recorded. | 6 month |
| plaque index | Measured by Manual UNC periodontal probe Scores: 0: No plaque
| 6 month |
| Glycosylated Haemoglobin (HbA1c %) | Measured by High performance liquid chromatography in mmol/mol | 6 month |
| Fasting plasma Glucose Level (FPG) | Measured by blood sampling in (mg/dl) | 6 month |
| Body Mass Index (BMI) | Measured in (Kg/m2) | 6 month |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |